2020 annual financial data
Puma Biotechnology 2020 Operating margin
Direct answer
Operating margin was -13.51%.
Operating income was -30,402,000 USD and net income was -59,995,000 USD.
Operating cash flow was 800,000 USD.
Get free Puma Biotechnology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 225,110,000 USD
- Operating income
- -30,402,000 USD
- Net income
- -59,995,000 USD
- Operating cash flow
- 800,000 USD